Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
import alert
Pharma
China deals, Daiichi-Merck ADC, Sun Pharma—Fierce Pharma Asia
Trump is reportedly considering limiting drug licensing deals with China. Daiichi and Merck's B7-H3 ADC heads to the FDA. Plus more.
Angus Liu
Sep 11, 2025 8:50pm
Sun plant placed on FDA import alert over contamination issues
Sep 11, 2025 9:25am
FDA hands out warning letters to 2 Chinese API manufacturers
Feb 11, 2025 2:30pm
FDA warning letter reveals production errors at Viatris plant
Jan 6, 2025 4:20pm
FDA put Intas plant on import alert, warning letter shows
Nov 29, 2023 1:26pm
India's Intas gets more bad news from FDA with import alert
Jun 5, 2023 10:40am
